Principles of polyoma- and papillomavirus uncoating

Medical Microbiology and Immunology

Volumn 201, Issue 4, 2012, Pages 427-436

  Cerqueira, Carla ^a   Schelhaas, Mario ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Papillomavirus; Polyomavirus; Virus entry; Virus structure; Virus uncoating

Indexed keywords

CELL COMPARTMENTALIZATION; CELL TRANSPORT; CONFORMATIONAL TRANSITION; DISULFIDE BOND; ENDOCYTOSIS; ENDOPLASMIC RETICULUM; ENDOPLASMIC RETICULUM ASSOCIATED DEGRADATION; EXTRACELLULAR MATRIX; GENETIC SIMILARITY; HUMAN PAPILLOMAVIRUS TYPE 33; MERKEL CELL POLYOMAVIRUS; NONHUMAN; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; POLYOMA VIRUS; PRIORITY JOURNAL; REVIEW; VIRAL GENETICS; VIRION; VIRUS ATTACHMENT; VIRUS CAPSID; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS ENVELOPE; VIRUS LIKE AGENT; VIRUS MORPHOLOGY; VIRUS PARTICLE; VIRUS SHEDDING; VIRUS TRANSMISSION; VIRUS UNCOATING;

HOST-PATHOGEN INTERACTIONS; HUMANS; PAPILLOMAVIRIDAE; POLYOMAVIRUS; VIRUS UNCOATING;

EID: 84867881070     PISSN: 03008584     EISSN: 14321831     Source Type: Journal    
DOI: 10.1007/s00430-012-0262-1     Document Type: Review

References (135)

1. Greber UF, Singh I, Helenius A (1994) Mechanisms of virus uncoating. Trends Microbiol 2(2):52-56
2. Howley PM, Lowy DR (2007) Papillomaviruses. In: Fields BN, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE, Knipe DM (eds) Fields Virology, 5th edn. Lippincott Williams and Wilkins, Philadelphia, PA, USA, p 2300-2354
3. Imperiale MJ, Major EO (2007) Polyomavirus. In: Fields BN, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE, Knipe DM (eds) Fields Virology, 5th edn. Lippincott Williams and Wilkins, Philadelphia, PA, USA, p 2268-2282
4. Feng H, Shuda M, Chang Y, Moore PS (2008) Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 319(5866):1096-1100. doi:10.1126/science.1152586
5. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H (2004) Classification of papillomaviruses. Virology 324(1): 17-27. doi:10.1016/j.virol. 2004.03.033
6. Sapp M, Day PM (2009) Structure, attachment and entry of polyoma- and papillomaviruses. Virology 384(2):400-409. doi: 10.1016/j.virol.2008.12.022
7. Tsai B, Qian M (2010) Cellular entry of polyomaviruses. Curr Top Microbiol Immunol 343:177-194. doi:10.1007/82-2010-38
8. Neu U, Stehle T, Atwood WJ (2009) The Polyomaviridae: contributions of virus structure to our understanding of virus receptors and infectious entry. Virology 384(2):389-399. doi: 10.1016/j.virol.2008.12.021
9. Longworth MS, Laimins LA (2004) Pathogenesis of human papillomaviruses in differentiating epithelia. Microbiol Mol Biol Rev 68(2):362-372
10. Buck CB, Pastrana DV, Lowy DR, Schiller JT (2004) Efficient intracellular assembly of papillomaviral vectors. J Virol 78(2): 751-757
11. Van Regenmortel M, Fauquet C, Bishop D, Carstens E, Estes M, Lemon S, Maniloff J, Mayo M, McGeoch D, Pringle C, Wickner R (2000) Virus taxonomy. Seventh Report of the International Committee on Taxonomy of Viruses Academic Press, San Diego, New York
12. Klug A, Finch JT (1965) Structure of Viruses of the Papilloma- Polyoma Type. I. Human Wart Virus. J Mol Biol 11:403-423
13. Liddington RC, Yan Y, Moulai J, Sahli R, Benjamin TL, Harrison SC (1991) Structure of simian virus 40 at 3.8-A resolution. Nature 354(6351):278-284
14. Baker TS, Newcomb WW, Olson NH, Cowsert LM, Olson C, Brown JC (1991) Structures of bovine and human papillomaviruses. Analysis by cryoelectron microscopy and threedimensional image reconstruction. Biophys J 60(6):1445-1456
15. Stehle T, Gamblin SJ, Yan Y, Harrison SC (1996) The structure of simian virus 40 refined at 3.1Aresolution. Structure 4(2):165-182
16. Chen XS, Garcea RL, Goldberg I, Casini G, Harrison SC (2000) Structure of small virus-like particles assembled from the L1 protein of human papillomavirus 16. Mol Cell 5(3):557-567
17. Bishop B, Dasgupta J, Klein M, Garcea RL, Christensen ND, Zhao R, Chen XS (2007) Crystal structures of four types of human papillomavirus L1 capsid proteins: understanding the specificity of neutralizing monoclonal antibodies. J Biol Chem 282(43):31803-31811. doi:10.1074/jbc.M706380200
18. Murata H, Teferedegne B, Sheng L, Lewis AM Jr, Peden K (2008) Identification of a neutralization epitope in the VP1 capsid protein of SV40. Virology 381(1):116-122. doi:10.1016/j.virol.2008.07.032
19. Modis Y, Trus BL, Harrison SC (2002) Atomic model of the papillomavirus capsid. EMBO J 21(18):4754-4762
20. Brady JN, Kendall JD, Consigli RA (1979) In vitro reassembly of infectious polyoma virions. J Virol 32(2):640-647
21. Brady JN, Winston VD, Consigli RA (1977) Dissociation of polyoma virus by the chelation of calcium ions found associated with purified virions. J Virol 23(3):717-724
22. Ishizu KI, Watanabe H, Han SI, Kanesashi SN, Hoque M, Yajima H, Kataoka K, Handa H (2001) Roles of disulfide linkage and calcium ion-mediated interactions in assembly and disassembly of virus-like particles composed of simian virus 40 VP1 capsid protein. J Virol 75(1):61-72. doi:10.1128/JVI.75.1. 61-72.2001
23. Hanslip SJ, Zaccai NR, Middelberg AP, Falconer RJ (2006) Assembly of human papillomavirus type-16 virus-like particles: multifactorial study of assembly and competing aggregation. Biotechnol Prog 22(2):554-560. doi:10.1021/bp0502781
24. Paintsil J, Muller M, Picken M, Gissmann L, Zhou J (1998) Calcium is required in reassembly of bovine papillomavirus in vitro. J Gen Virol 79(Pt 5):1133-1141
25. McCarthy MP, White WI, Palmer-Hill F, Koenig S, Suzich JA (1998) Quantitative disassembly and reassembly of human papillomavirus type 11 viruslike particles in vitro. J Virol 72(1): 32-41
26. Sapp M, Fligge C, Petzak I, Harris JR, Streeck RE (1998) Papillomavirus assembly requires trimerization of the major capsid protein by disulfides between two highly conserved cysteines. J Virol 72(7):6186-6189
27. Sapp M, Volpers C, Muller M, Streeck RE (1995) Organization of the major and minor capsid proteins in human papillomavirus type 33 virus-like particles. J Gen Virol 76(Pt 9):2407-2412
28. Li M, Beard P, Estes PA, Lyon MK, Garcea RL (1998) Intercapsomeric disulfide bonds in papillomavirus assembly and disassembly. J Virol 72(3):2160-2167
29. Ishii Y, Tanaka K, Kanda T (2003) Mutational analysis of human papillomavirus type 16 major capsid protein L1: the cysteines affecting the intermolecular bonding and structure of L1-capsids. Virology 308(1):128-136
30. Conway MJ, Cruz L, Alam S, Christensen ND, Meyers C (2011) Differentiation-dependent interpentameric disulfide bond stabilizes native human papillomavirus type 16. PLoS ONE 6(7):e22427. doi:10.1371/journal.pone.0022427
31. Stehle T, Harrison SC (1996) Crystal structures of murine polyomavirus in complex with straight-chain and branched-chain sialyloligosaccharide receptor fragments. Structure 4(2):183-194
32. Krauzewicz N, Streuli CH, Stuart-Smith N, Jones MD, Wallace S, Griffin BE (1990) Myristylated polyomavirus VP2: role in the life cycle of the virus. J Virol 64(9):4414-4420
33. Sahli R, Freund R, Dubensky T, Garcea R, Bronson R, Benjamin T (1993) Defect in entry and altered pathogenicity of a polyoma virus mutant blocked in VP2 myristylation. Virology 192(1):142-153. doi:10.1006/viro.1993.1016
34. Gasparovic ML, Gee GV, Atwood WJ (2006) JC virus minor capsid proteins Vp2 and Vp3 are essential for virus propagation. J Virol 80(21):10858-10861. doi:10.1128/JVI.01298-06
35. Baker TS, Drak J, Bina M (1989) The capsid of small papova viruses contains 72 pentameric capsomeres: direct evidence from cryo-electron-microscopy of simian virus 40. Biophys J 55(2):243-253. doi:10.1016/S0006-3495(89)82799-7
36. Griffith JP, Griffith DL, Rayment I, Murakami WT, Caspar DL (1992) Inside polyomavirus at 25-A resolution. Nature 355(6361):652-654. doi:10.1038/355652a0
37. Buck CB, Cheng N, Thompson CD, Lowy DR, Steven AC, Schiller JT, Trus BL (2008) Arrangement of L2 within the Papillomavirus capsid. J Virol 82(11):5190-5197
38. Chen XS, Stehle T, Harrison SC (1998) Interaction of polyomavirus internal protein VP2 with the major capsid protein VP1 and implications for participation of VP2 in viral entry. EMBO J 17(12):3233-3240. doi:10.1093/emboj/17.12.3233
39. Finnen RL, Erickson KD, Chen XS, Garcea RL (2003) Interactions between papillomavirus L1 and L2 capsid proteins. J Virol 77(8):4818-4826
40. Okun MM, Day PM, Greenstone HL, Booy FP, Lowy DR, Schiller JT, Roden RB (2001) L1 interaction domains of papillomavirus l2 necessary for viral genome encapsidation. J Virol 75(9):4332-4342. doi:10.1128/JVI.75.9.4332-4342.2001
41. Barouch DH, Harrison SC (1994) Interactions among the major and minor coat proteins of polyomavirus. J Virol 68(6):3982-3989
42. Norkin LC, Anderson HA, Wolfrom SA, Oppenheim A (2002) Caveolar endocytosis of simian virus 40 is followed by brefeldin A-sensitive transport to the endoplasmic reticulum, where the virus disassembles. J Virol 76(10):5156-5166
43. Kawana Y, Kawana K, Yoshikawa H, Taketani Y, Yoshiike K, Kanda T (2001) Human papillomavirus type 16 minor capsid protein l2 N-terminal region containing a common neutralization epitope binds to the cell surface and enters the cytoplasm. J Virol 75(5):2331-2336
44. Kondo K, Ishii Y, Ochi H, Matsumoto T, Yoshikawa H, Kanda T (2007) Neutralization of HPV16, 18, 31, and 58 pseudovirions with antisera induced by immunizing rabbits with synthetic peptides representing segments of the HPV16 minor capsid protein L2 surface region. Virology 358(2):266-272. doi: 10.1016/j.virol.2006.08.037
45. Liu WJ, Gissmann L, Sun XY, Kanjanahaluethai A, Muller M, Doorbar J, Zhou J (1997) Sequence close to the N-terminus of L2 protein is displayed on the surface of bovine papillomavirus type 1 virions. Virology 227(2):474-483. doi:10.1006/viro.1996.8348
46. Richards RM, Lowy DR, Schiller JT, Day PM (2006) Cleavage of the papillomavirus minor capsid protein, L2, at a furin consensus site is necessary for infection. Proc Nat Acad Sci USA 103(5):1522-1527
47. Yang R, Day PM, Yutzy WH, Lin KY, Hung CF, Roden RB (2003) Cell surface-binding motifs of L2 that facilitate papillomavirus infection. J Virol 77(6):3531-3541
48. Li PP, Nakanishi A, Clark SW, Kasamatsu H (2002) Formation of transitory intrachain and interchain disulfide bonds accompanies the folding and oligomerization of simian virus 40 Vp1 in the cytoplasm. Proc Nat Acad Sci USA 99(3):1353-1358. doi: 10.1073/pnas.032668699
49. Dean DA, Li PP, Lee LM, Kasamatsu H (1995) Essential role of the Vp2 and Vp3 DNA-binding domain in simian virus 40 morphogenesis. J Virol 69(2):1115-1121
50. Bordeaux J, Forte S, Harding E, Darshan MS, Klucevsek K, Moroianu J (2006) The l2 minor capsid protein of low-risk human papillomavirus type 11 interacts with host nuclear import receptors and viral DNA. J Virol 80(16):8259-8262. doi:10.1128/JVI.00776-06
51. Buck CB, Thompson CD, Pang YY, Lowy DR, Schiller JT (2005) Maturation of papillomavirus capsids. J Virol 79(5):2839-2846. doi:10.1128/JVI.79.5.2839-2846. 2005
52. Conway MJ, Alam S, Ryndock EJ, Cruz L, Christensen ND, Roden RB, Meyers C (2009) Tissue-spanning redox gradientdependent assembly of native human papillomavirus type 16 virions. J Virol 83(20):10515-10526. doi:10.1128/JVI. 00731-09
53. Low JA, Magnuson B, Tsai B, Imperiale MJ (2006) Identification of gangliosides GD1b and GT1b as receptors for BK virus. J Virol 80(3):1361-1366. doi:10.1128/JVI.80.3.1361-1366.2006
54. Smith AE, Lilie H, Helenius A (2003) Ganglioside-dependent cell attachment and endocytosis of murine polyomavirus-like particles. FEBS Lett 555(2):199-203
55. Tsai B, Gilbert JM, Stehle T, Lencer W, Benjamin TL, Rapoport TA (2003) Gangliosides are receptors for murine polyoma virus and SV40. EMBO J 22(17):4346-4355
56. Neu U, Woellner K, Gauglitz G, Stehle T (2008) Structural basis of GM1 ganglioside recognition by simian virus 40. Proc Nat Acad Sci USA 105(13):5219-5224. doi:10.1073/pnas.0710301105
57. Campanero-Rhodes MA, Smith A, Chai W, Sonnino S, Mauri L, Childs RA, Zhang Y, Ewers H, Helenius A, Imberty A, Feizi T (2007) N-glycolyl GM1 ganglioside as a receptor for simian virus 40. J Virol 81(23):12846-12858. doi:10.1128/JVI.01311-07
58. Neu U, Bauer J, Stehle T (2011) Viruses and sialic acids: rules of engagement. Curr Opin Struct Biol 21(5):610-618. doi: 10.1016/j.sbi.2011.08.009
59. Qian M, Tsai B (2010) Lipids and proteins act in opposing manners to regulate polyomavirus infection. J Virol 84(19): 9840-9852. doi:10.1128/JVI. 01093-10
60. Liu CK, Wei G, Atwood WJ (1998) Infection of glial cells by the human polyomavirus JC is mediated by an N-linked glycoprotein containing terminal alpha(2-6)-linked sialic acids. J Virol 72(6):4643-4649
61. Neu U, Maginnis MS, Palma AS, Stroh LJ, Nelson CD, Feizi T, Atwood WJ, Stehle T (2010) Structure-function analysis of the human JC polyomavirus establishes the LSTc pentasaccharide as a functional receptor motif. Cell Host Microbe 8(4):309-319. doi:10.1016/j.chom.2010.09.004
62. Maginnis MS, Haley SA, Gee GV, Atwood WJ (2010) Role of N-linked glycosylation of the 5-HT2A receptor in JC virus infection. J Virol 84(19):9677-9684. doi:10.1128/JVI.00978-10
63. Schowalter RM, Pastrana DV, Buck CB (2011) Glycosaminoglycans and sialylated glycans sequentially facilitate Merkel cell polyomavirus infectious entry. PLoS Pathog 7(7):e1002161. doi: 10.1371/journal.ppat.1002161
64. Stehle T, Harrison SC (1997) High-resolution structure of a polyomavirus VP1-oligosaccharide complex: implications for assembly and receptor binding. EMBO J 16(16):5139-5148
65. Stehle T, Yan Y, Benjamin TL, Harrison SC (1994) Structure of murine polyomavirus complexed with an oligosaccharide receptor fragment. Nature 369(6476):160-163
66. Cavaldesi M, Caruso M, Sthandier O, Amati P, Garcia MI (2004) Conformational changes of murine polyomavirus capsid proteins induced by sialic acid binding. J Biol Chem 279(40):41573-41579. doi:10.1074/jbc.M405995200
67. Anderson HA, Chen Y, Norkin LC (1996) Bound simian virus 40 translocates to caveolin-enriched membrane domains, and its entry is inhibited by drugs that selectively disrupt caveolae. Mol Biol Cell 7(11):1825-1834
68. Damm EM, Pelkmans L, Kartenbeck J, Mezzacasa A, Kurzchalia T, Helenius A (2005) Clathrin- and caveolin-1-independent endocytosis: entry of simian virus 40 into cells devoid of caveolae. J Cell Biol 168(3):477-488
69. Pelkmans L, Kartenbeck J, Helenius A (2001) Caveolar endocytosis of simian virus 40 reveals a new two-step vesiculartransport pathway to the ER. Nat Cell Biol 3(5):473-483
70. Pelkmans L, Puntener D, Helenius A (2002) Local actin polymerization and dynamin recruitment in SV40-induced internalization of caveolae. Science 296(5567):535-539
71. Querbes W, Benmerah A, Tosoni D, Di Fiore PP, Atwood WJ (2004) A JC virus-induced signal is required for infection of glial cells by a clathrin- and eps15-dependent pathway. J Virol 78(1):250-256
72. Pho MT, Ashok A, Atwood WJ (2000) JC virus enters human glial cells by clathrin-dependent receptor-mediated endocytosis. J Virol 74(5):2288-2292
73. Engel S, Heger T, Mancini R, Herzog F, Kartenbeck J, Hayer A, Helenius A (2011) Role of endosomes in simian virus 40 entry and infection. J Virol 85(9):4198-4211. doi:10.1128/JVI.02179-10
74. Kartenbeck J, Stukenbrok H, Helenius A (1989) Endocytosis of simian virus 40 into the endoplasmic reticulum. J Cell Biol 109(6 Pt 1):2721-2729
75. Qian M, Cai D, Verhey KJ, Tsai B (2009) A lipid receptor sorts polyomavirus from the endolysosome to the endoplasmic reticulum to cause infection. PLoS Pathog 5(6):e1000465. doi: 10.1371/journal.ppat.1000465
76. Schelhaas M, Malmstrom J, Pelkmans L, Haugstetter J, Ellgaard L, Grunewald K, Helenius A (2007) Simian virus 40 depends on ER protein folding and quality control factors for entry into host cells. Cell 131(3):516-529
77. Schelhaas M (2010) Come in and take your coat off - how host cells provide endocytosis for virus entry. Cell Microbiol 12(10):1378-1388. doi:10.1111/j.1462-5822.2010.01510.x
78. Jiang M, Abend JR, Tsai B, Imperiale MJ (2009) Early events during BK virus entry and disassembly. J Virol 83(3):1350-1358. doi:10.1128/JVI.02169-08
79. Inoue T, Moore P, Tsai B (2011) How viruses and toxins disassemble to enter host cells. Annu Rev Microbiol 65:287-305. doi:10.1146/annurev-micro- 090110-102855
80. Inoue T, Tsai B (2011) A large and intact viral particle penetrates the endoplasmic reticulum membrane to reach the cytosol. PLoS Pathog 7(5):e1002037. doi:10.1371/journal.ppat.1002037
81. Gilbert J, Ou W, Silver J, Benjamin T (2006) Downregulation of protein disulfide isomerase inhibits infection by the mouse polyomavirus. J Virol 80(21):10868-10870. doi:10.1128/JVI.01117-06
82. Walczak CP, Tsai B (2011) A PDI family network acts distinctly and coordinately with ERp29 to facilitate polyomavirus infection. J Virol 85(5):2386-2396. doi:10.1128/JVI.01855-10
83. Geiger R, Andritschke D, Friebe S, Herzog F, Luisoni S, Heger T, Helenius A (2011) BAP31 and BiP are essential for dislocation of SV40 from the endoplasmic reticulum to the cytosol. Nat Cell Biol 13(11):1305-1314. doi:10.1038/ncb2339
84. GoodwinEC, Lipovsky A, Inoue T,MagaldiTG, EdwardsAP,Van Goor KE, Paton AW, Paton JC, Atwood WJ, Tsai B, Di Maio D (2011) BiP and multiple DNAJ molecular chaperones in the endoplasmic reticulum are required for efficient simian virus infection.mBio 2(3):e00101-e00111. doi:10.1128/mBio.00101-11
85. Magnuson B, Rainey EK, Benjamin T, Baryshev M, Mkrtchian S, Tsai B (2005) ERp29 triggers a conformational change in polyomavirus to stimulate membrane binding. Mol Cell 20(2): 289-300
86. Rainey-Barger EK, Magnuson B, Tsai B (2007) A chaperoneactivated nonenveloped virus perforates the physiologically relevant endoplasmic reticulum membrane. J Virol 81(23): 12996-13004. doi:10.1128/JVI.01037-07
87. Kuksin D, Norkin LC (2012) Disassembly of simian virus 40 during passage through the endoplasmic reticulum and in the cytoplasm. J Virol 86(3):1555-1562. doi:10.1128/JVI.05753-11
88. Daniels R, Rusan NM, Wadsworth P, Hebert DN (2006) SV40 VP2 and VP3 insertion into ER membranes is controlled by the capsid protein VP1: implications for DNA translocation out of the ER. Mol Cell 24(6):955-966. doi:10.1016/j.molcel.2006.11.001
89. Lilley BN, Gilbert JM, Ploegh HL, Benjamin TL (2006) Murine polyomavirus requires the endoplasmic reticulum protein Derlin-2 to initiate infection. J Virol 80(17):8739-8744. doi:10.1128/JVI.00791-06
90. Lilley BN, Ploegh HL (2004) A membrane protein required for dislocation of misfolded proteins from the ER. Nature 429(6994):834-840
91. Ye Y, Shibata Y, Yun C, Ron D, Rapoport TA (2004) A membrane protein complex mediates retro-translocation from the ER lumen into the cytosol. Nature 429(6994):841-847
92. Chromy LR, Oltman A, Estes PA, Garcea RL (2006) Chaperone- mediated in vitro disassembly of polyoma- and papillomaviruses. J Virol 80(10):5086-5091. doi:10.1128/JVI.80.10.5086-5091.2006
93. Li PP, Itoh N, Watanabe M, Shi Y, Liu P, Yang HJ, Kasamatsu H (2009) Association of simian virus 40 vp1 with 70-kilodalton heat shock proteins and viral tumor antigens. J Virol 83(1):37-46. doi:10.1128/JVI.00844-08
94. Florin L, Sapp M, Spoden G (2012) Host cell factors in papillomavirus entry. Med Microbiol Immunol. doi:10.1007/s00430-012-0270-1
95. Broutian TR, Brendle SA, Christensen ND (2010) Differential binding patterns to host cells associated with particles of several human alphapapillomavirus types. J Gen Virol 91(Pt 2):531-540. doi:10.1099/vir.0. 012732-0
96. Culp TD, Budgeon LR, Christensen ND (2006) Human papillomaviruses bind a basal extracellular matrix component secreted by keratinocytes which is distinct from a membraneassociated receptor. Virology 347(1):147-159
97. Culp TD, Budgeon LR, Marinkovich MP, Meneguzzi G, Christensen ND (2006) Keratinocyte-secreted laminin 5 can function as a transient receptor for human papillomaviruses by binding virions and transferring them to adjacent cells. J Virol 80(18):8940-8950
98. Selinka HC, Florin L, Patel HD, Freitag K, Schmidtke M, Makarov VA, Sapp M (2007) Inhibition of transfer to secondary receptors by heparan sulfate-binding drug or antibody induces noninfectious uptake of human papillomavirus. J Virol 81(20): 10970-10980
99. Joyce JG, Tung JS, Przysiecki CT, Cook JC, Lehman ED, Sands JA, Jansen KU, Keller PM (1999) The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes. J Biol Chem 274(9):5810-5822
100. Combita AL, Touze A, Bousarghin L, Sizaret PY, Munoz N, Coursaget P (2001) Gene transfer using human papillomavirus pseudovirions varies according to virus genotype and requires cell surface heparan sulfate. FEMS Microbiol Lett 204(1): 183-188
101. Giroglou T, Florin L, Schafer F, Streeck RE, Sapp M (2001) Human papillomavirus infection requires cell surface heparan sulfate. J Virol 75(3):1565-1570
102. Shafti-Keramat S, Handisurya A, Kriehuber E, Meneguzzi G, Slupetzky K, Kirnbauer R (2003) Different heparan sulfate proteoglycans serve as cellular receptors for human papillomaviruses. J Virol 77(24):13125-13135
103. Johnson KM, Kines RC, Roberts JN, Lowy DR, Schiller JT, Day PM (2009) Role of heparan sulfate in attachment to and infection of the murine female genital tract by human papillomavirus. J Virol 83(5):2067-2074. doi:10.1128/JVI.02190-08
104. Kines RC, Thompson CD, Lowy DR, Schiller JT, Day PM (2009) The initial steps leading to papillomavirus infection occur on the basement membrane prior to cell surface binding. Proc Nat Acad Sci USA 106(48):20458-20463. doi:10.1073/pnas.0908502106
105. Surviladze Z, Dziduszko A, Ozbun MA (2012) Essential roles for soluble virion-associated heparan sulfonated proteoglycans and growth factors in human papillomavirus infections. PLoS Pathog 8(2):e1002519. doi:10.1371/journal.ppat. 1002519
106. Roberts JN, Buck CB, Thompson CD, Kines R, Bernardo M, Choyke PL, Lowy DR, Schiller JT (2007) Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan. Nat Med 13(7):857-861
107. Buck CB, Thompson CD, Roberts JN, Muller M, Lowy DR, Schiller JT (2006) Carrageenan is a potent inhibitor of papillomavirus infection. PLoS Pathog 2(7):e69. doi:10.1371/journal.ppat.0020069
108. Patterson NA, Smith JL, Ozbun MA (2005) Human papillomavirus type 31b infection of human keratinocytes does not require heparan sulfate. J Virol 79(11):6838-6847. doi:10.1128/JVI.79.11.6838-6847.2005
109. Selinka HC, Giroglou T, Nowak T, Christensen ND, Sapp M (2003) Further evidence that papillomavirus capsids exist in two distinct conformations. J Virol 77(24):12961-12967
110. Day PM, Gambhira R, Roden RB, Lowy DR, Schiller JT (2008) Mechanisms of human papillomavirus type 16 neutralization by l2 cross-neutralizing and l1 type-specific antibodies. J Virol 82(9):4638-4646
111. Bienkowska-Haba M, Patel HD, Sapp M (2009) Target cell cyclophilins facilitate human papillomavirus type 16 infection. PLoS Pathog 5(7):e1000524. doi:10.1371/journal.ppat.1000524
112. Day PM, Baker CC, Lowy DR, Schiller JT (2004) Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression. Proc Nat Acad Sci USA 101(39):14252-14257. doi:10.1073/pnas. 0404229101
113. Day PM, Lowy DR, Schiller JT (2008) Heparan sulfate-independent cell binding and infection with furin-precleaved papillomavirus capsids. J Virol 82(24):12565-12568. doi:10.1128/JVI.01631-08
114. Schelhaas M, Shah B, Holzer M, Blattmann P, Kuhling L, Day PM, Schiller JT, Helenius A (2012) Entry of human papillomavirus type 16 by actin-dependent, clathrin- and lipid raftindependent endocytosis. PLoS Pathog 8(4):e1002657. doi: 10.1371/journal.ppat.1002657
115. Hindmarsh PL, Laimins LA (2007) Mechanisms regulating expression of the HPV 31 L1 and L2 capsid proteins and pseudovirion entry. Virol J 4:19. doi:10.1186/1743-422X-4-19
116. Bousarghin L, Touze A, Sizaret PY, Coursaget P (2003) Human papillomavirus types 16, 31, and 58 use different endocytosis pathways to enter cells. J Virol 77(6):3846-3850
117. Smith JL, Campos SK, Wandinger-Ness A, Ozbun MA (2008) Caveolin-1-dependent infectious entry of human papillomavirus type 31 in human keratinocytes proceeds to the endosomal pathway for pH-dependent uncoating. J Virol 82(19):9505-9512. doi:10.1128/JVI.01014-08
118. Smith JL, Campos SK, Ozbun MA (2007) Human papillomavirus type 31 uses a caveolin 1- and dynamin 2-mediated entry pathway for infection of human keratinocytes. J Virol 81(18): 9922-9931
119. Day PM, Lowy DR, Schiller JT (2003) Papillomaviruses infect cells via a clathrin-dependent pathway. Virology 307(1):1-11
120. Laniosz V, Holthusen KA, Meneses PI (2008) Bovine papillomavirus type 1: from clathrin to caveolin. J Virol 82(13): 6288-6298. doi:10.1128/JVI.00569-08
121. Spoden G, Freitag K, Husmann M, Boller K, Sapp M, Lambert C, Florin L (2008) Clathrin- and caveolin-independent entry of human papillomavirus type 16-involvement of tetraspaninenriched microdomains (TEMs). PLoS ONE 3(10):e3313. doi: 10.1371/journal.pone.0003313
122. Bienkowska-Haba M, Williams C, Kim SM, Garcea RL, Sapp M (2012) Cyclophilins facilitate dissociation of the HPV16 capsid protein L1 from the L2/DNA complex following virus entry. J Virol. doi:10.1128/JVI.00980-12
123. Selinka HC, Giroglou T, Sapp M (2002) Analysis of the infectious entry pathway of human papillomavirus type 33 pseudovirions. Virology 299(2):279-287
124. Dabydeen SA, Meneses PI (2009) The role of NH4Cl and cysteine proteases in Human Papillomavirus type 16 infection. Virol J 6:109. doi:10.1186/1743-422X- 6-109
125. Karanam B, Peng S, Li T, Buck C, Day PM, Roden RB (2010) Papillomavirus infection requires gamma secretase. J Virol 84(20):10661-10670. doi:10.1128/JVI.01081-10
126. Bergant Marusic M, Ozbun MA, Campos SK, Myers MP, Banks L (2012) Human papillomavirus L2 facilitates viral escape from late endosomes via sorting nexin 17. Traffic 13(3):455-467. doi: 10.1111/j.1600-0854.2011.01320.x
127. Campos SK, Ozbun MA (2009) Two highly conserved cysteine residues in HPV16 L2 form an intramolecular disulfide bond and are critical for infectivity in human keratinocytes. PLoS ONE 4(2):e4463. doi:10.1371/journal.pone.0004463
128. Sapp M, Kraus U, Volpers C, Snijders PJ, Walboomers JM, Streeck RE (1994) Analysis of type-restricted and cross-reactive epitopes on virus-like particles of human papillomavirus type 33 and in infected tissues using monoclonal antibodies to the major capsid protein. J Gen Virol 75(Pt 12):3375-3383
129. Schneider MA, Spoden GA, Florin L, Lambert C (2011) Identification of the dynein light chains required for human papillomavirus infection. Cell Microbiol 13(1):32-46. doi:10.1111/j.1462-5822.2010.01515.x
130. Campos SK, Chapman JA, Deymier MJ, Bronnimann MP, Ozbun MA (2012) Opposing effects of bacitracin on human papillomavirus type 16 infection: enhancement of binding and entry and inhibition of endosomal penetration. J Virol 86(8): 4169-4181. doi:10.1128/JVI.05493-11
131. Karala AR, Ruddock LW (2010) Bacitracin is not a specific inhibitor of protein disulfide isomerase. FEBS J 277(11): 2454-2462. doi:10.1111/j.1742-4658. 2010.07660.x
132. Kamper N, Day PM, Nowak T, Selinka HC, Florin L, Bolscher J, Hilbig L, Schiller JT, Sapp M (2006) A membrane-destabilizing peptide in capsid protein L2 is required for egress of papillomavirus genomes from endosomes. J Virol 80(2): 759-768. doi:10.1128/JVI.80.2.759-768.2006
133. Baker TS, Drak J, Bina M (1988) Reconstruction of the threedimensional structure of simian virus 40 and visualization of the chromatin core. Proc Nat Acad Sci USA 85(2):422-426
134. Rayment I, Baker TS, Caspar DL, Murakami WT (1982) Polyoma virus capsid structure at 22.5 A resolution. Nature 295(5845):110-115
135. Roth SD, Sapp M, Streeck RE, Selinka HC (2006) Characterization of neutralizing epitopes within the major capsid protein of human papillomavirus type 33. Virol J 3:83